Shetty Aishwarya N, Kattan Gonzalo Sepulveda, Javed Muhammad, Pearce Christopher, Buttery Jim P, Clothier Hazel J
Epidemiology Informatics, Centre for Health Analytics, Melbourne Children's Campus, Melbourne, Australia; SAEFVIC, Murdoch Childrens Research Institute, Melbourne, Australia.
Aurora Primary Care Research Institute, Blackburn, Australia.
Vaccine. 2025 Aug 30;62:127511. doi: 10.1016/j.vaccine.2025.127511. Epub 2025 Jul 21.
Stories of menstrual changes occurring post COVID-19 vaccination have abounded, with many affected persons expressing frustration their concerns were not being heard. In an era where misinformation is rampant and can fuel vaccine hesitancy it is imperative to address and validate community concerns. We aimed to investigate evidence of increased menstrual disturbances associated with COVID-19 vaccination.
We adopted a two-pronged approach; firstly, scrutinising social-media for discussions on menstrual changes associated with COVID-19 vaccination using our deep learning framework VaxPulse. Secondly, we analysed a large de-identified Australian general practice dataset to validate any evidence of increased menstrual disturbance presentations for females aged 15-49 years post-COVID-19 vaccination from 1 January 2021 to 28 March 2023, stratified by vaccine platform (adenovirus vector, mRNA, or protein-subunit). We used a self-controlled case series (SCCS) analysis to determine the relative incidence (RI) with 95 % confidence interval (CI) at six weeks post-vaccination and monitored thereafter until a return to baseline for minimum 2 consecutive weeks.
Examining Reddit and Twitter (now X) data, we identified 70,977 posts discussing menstrual cycle irregularities with two prominent peaks since the global COVID-19 vaccine rollout. The SCCS analysis demonstrated increased presentations with a menstrual disturbance diagnosis associated with mRNA COVID-19 vaccination (RI: 1.14, 95 %CI: 1.07, 1.22, P < 0.001). The increase in presentations was still evident at 7 weeks but dissipated by 13 weeks post vaccination. (RI:1.03, 95 %CI: 0.91, 1.16, P = 0.20).
This study demonstrated a transient increase in menstrual change presentations for up to three months following COVID-19 mRNA vaccination. These findings affirm community concerns raised on social media and are important to ensure people who are vaccinated or are considering future vaccines feel heard, supported, and validated. Our analyses highlight the value of using large real-world datasets to gather reliable evidence for public health decision-making.
关于新冠疫苗接种后出现月经变化的报道大量涌现,许多受影响者表示沮丧,因为他们的担忧未被倾听。在错误信息泛滥且可能助长疫苗犹豫情绪的时代,解决并证实公众的担忧至关重要。我们旨在调查与新冠疫苗接种相关的月经紊乱增加的证据。
我们采用了双管齐下的方法;首先,使用我们的深度学习框架VaxPulse,在社交媒体上仔细查看关于与新冠疫苗接种相关的月经变化的讨论。其次,我们分析了一个经过去识别处理的大型澳大利亚全科医疗数据集,以验证2021年1月1日至2023年3月28日期间15至49岁女性在接种新冠疫苗后月经紊乱症状增加的任何证据,并按疫苗平台(腺病毒载体、信使核糖核酸或蛋白质亚单位)进行分层。我们使用自我对照病例系列(SCCS)分析来确定接种疫苗六周后的相对发病率(RI)及其95%置信区间(CI),并在之后进行监测,直到连续至少两周恢复到基线水平。
通过检查Reddit和推特(现称X)的数据,我们确定了70977条讨论月经周期不规律的帖子,自全球新冠疫苗推出以来有两个显著高峰。SCCS分析表明,与新冠信使核糖核酸疫苗接种相关的月经紊乱诊断症状有所增加(相对发病率:1.14,95%置信区间:1.07,1.22,P<0.001)。接种后7周时症状增加仍很明显,但在接种后13周时消失。(相对发病率:1.03,95%置信区间:0.91,1.16,P = 0.20)。
本研究表明,新冠信使核糖核酸疫苗接种后长达三个月内,月经变化症状出现短暂增加。这些发现证实了社交媒体上提出的公众担忧,对于确保已接种疫苗或正在考虑未来接种疫苗的人感到被倾听、得到支持和认可非常重要。我们的分析凸显了使用大型真实世界数据集为公共卫生决策收集可靠证据的价值。